Waiv, formerly Owkin Dx
AI-powered clinical diagnostic solutions
- B2B
- AI-native
About Waiv, formerly Owkin Dx
Develop advanced AI-driven diagnostics integrating complex biomarker data to enhance precision medicine and improve patient treatment and monitoring outcomes.
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2026
- Revenue
- $10.1M – $80.1MTamtam estimate
- Website
- wearewaiv.com
- linkedin.com/company/we-are-waiv
Waiv, formerly Owkin Dx at a glance
Waiv, formerly Owkin Dx is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
Waiv, formerly Owkin Dx was founded in 2026.
Waiv, formerly Owkin Dx has 51–250 employees.
Waiv, formerly Owkin Dx's revenue is $10.1M – $80.1M (Tamtam estimate).
Selling to companies like Waiv, formerly Owkin Dx?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies